These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31258094)

  • 1. Comparison of 99mTc Injected Activity with Prescribed Activity in Four Types of Nuclear Medicine Exams.
    Khan MI; Farwa U; Iqbal T; Ali S; Nazir A; Ijaz M
    Curr Radiopharm; 2020; 13(1):80-85. PubMed ID: 31258094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Technetium-99m production for use in nuclear medicine].
    Vucina J
    Med Pregl; 2000; 53(11-12):631-4. PubMed ID: 11320753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Tc-99m in diagnostic radiopharmaceuticals.
    Banerjee S; Pillai MR; Ramamoorthy N
    Semin Nucl Med; 2001 Oct; 31(4):260-77. PubMed ID: 11710769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radionuclide purity of 99mTC eluate for use in nuclear medicine].
    Vucina JL
    Med Pregl; 1996; 49(1-2):41-4. PubMed ID: 8643069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of absolute renal uptake with technetium-99m dimercaptosuccinic acid: direct comparison with the radioactivity of nephrectomy specimens.
    Lopes de Lima Mda C; Ramos CD; Brunetto SQ; Lopes de Lima M; Ferreira U; Sá Camargo Etchebehere EC; Santos Ade O; Rodrigues Netto Júnior N; Camargo EE
    Sao Paulo Med J; 2008 May; 126(3):150-5. PubMed ID: 18711653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear medicine.
    Maisey MN
    Practitioner; 1978 Mar; 220(1317):445-51. PubMed ID: 643790
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
    Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
    Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiopharmacokinetic data for 99mTc-ABP--a new radiopharmaceutical for bone scanning: comparison with 99mTc-MDP.
    Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina CE; Sepúlveda-Méndez J
    Nucl Med Biol; 1997 Jan; 24(1):27-33. PubMed ID: 9080472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
    Lerthirunwong C; Cheng KT; Hladik WB
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemistry of 99mTc-labeled radiopharmaceuticals.
    Dewanjee MK
    Semin Nucl Med; 1990 Jan; 20(1):5-27. PubMed ID: 2404341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simplicity or complexity of the radiopharmaceutical production process in the light of optimization of radiation protection of staff - 99mTc vs. 18F].
    Wrzesień M
    Med Pr; 2018 May; 69(3):317-327. PubMed ID: 29790486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid uptake and scintigraphy using 99mTc pertechnetate: standardization in normal individuals.
    Ramos CD; Zantut Wittmann DE; Etchebehere EC; Tambascia MA; Silva CA; Camargo EE
    Sao Paulo Med J; 2002 Mar; 120(2):45-8. PubMed ID: 11994772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of residual activities in 99mTc generators and 81mKr generators].
    Muto T
    Radioisotopes; 1987 Oct; 36(10):530-3. PubMed ID: 3438497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal evaluations.
    Gomes ML; de Mattos DM; de Souza Freitas R; Bezerra RJ; Bernardo-Filho M
    Hum Exp Toxicol; 2001 Apr; 20(4):193-7. PubMed ID: 11393272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromine-82 contamination in fission product 99mTc-generator eluate.
    McAuley R; Lull R; Ice R
    Eur J Nucl Med; 1985; 10(1-2):60-2. PubMed ID: 3979411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of 99Mo measurement in 99mTc eluate samples using a scintillation detection system.
    Dantas AL; Ribeiro BS; Souza RS; Lucena EA; Dantas BM
    Health Phys; 2010 Oct; 99(4):453-6. PubMed ID: 20838085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future of low specific activity molybdenum-99/technetium-99m generator.
    Mushtaq A
    Curr Radiopharm; 2012 Oct; 5(4):325-8. PubMed ID: 22642420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation dose from radiopharmaceuticals contaminated with molybdenum-99.
    Shearer DR; Pezzullo JC; Moore MM; Coleman P; Frater SI
    J Nucl Med; 1988 May; 29(5):695-700. PubMed ID: 2836569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered 99mTc-pertechnetate distribution in a thyroid scan after 99mTc-Sn pyrophosphate administration.
    Montelibano EB; Ford DR; Sayle BA
    Clin Nucl Med; 1979 Jul; 4(7):277-82. PubMed ID: 223800
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of technetium-99m wastage in selected private sector nuclear medicine imaging departments.
    Mathurine G; Bresser P; Teixeira N
    Nucl Med Commun; 2013 Dec; 34(12):1233-6. PubMed ID: 24089081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.